Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Senior Advisor to private equity firm; Consultant to medical device and biotech companies; Executive VP and CFO of biotech company; No mention of software or programming skills. |
| 2022-04-27 | J.D. from University of Michigan Law School; A.B. in Politics from Princeton University; Senior Advisor to Prettybrook Partners; Consultant to SparkMed Advisors LLC; Executive Vice President and Chief Financial Officer of NewLink Genetics Corporation. |
| 2023-05-01 | Education • J.D. from University of Michigan Law School Relevant Skills • Medical Devices/Pharmaceutical Experience and M&A/Business Development Expertise - developed during his more than 25 years of senior management experience in the medical technology and biotechnology industries |
| 2024-06-11 | Education • J.D. from University of Michigan Law School • A.B. in Politics from Princeton University |
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-27 | Mr. Henneman received an A.B. in Politics from Princeton University and a J.D. from the University of Michigan Law School. He has extensive experience in finance, legal affairs, business transactions, and mergers and acquisitions. |
| 2024-04-29 | Mr. Henneman has more than 25 years of combined financial and operational management experience in the life sciences industry. He received an A.B. in Politics from Princeton University and a J.D. from the University of Michigan Law School. |
Data sourced from SEC filings. Last updated: 2025-10-12